BUSINESS● LOWSep 9 · Sep 9, 2026, 5:07 AM
Can-Fite Biopharma GAAP EPS of -$1.24, revenue of $0.2M
Seeking Alpha Tech · middle east
Can-Fite Biopharma reported GAAP Earnings Per Share of -$1.24 and revenue of $0.2 million, indicating its financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowAviation: with the takeover of TAP, can Lufthansa challenge Air France-KLM in Africa?Jeune AfriqueBUSINESS25m agoTreasury yields slide as investors flee to safety of bonds amid tech routCNBC